Skip to Content
The 190th General Court of the Commonwealth of Massachusetts

Section 2D: Massachusetts AIDS Fund; definitions

[ Text of section effective until April 11, 2017. For text effective April 11, 2017, see below.]

  Section 2D. As used in sections two D to two F, inclusive, the following words shall, unless the context clearly indicates otherwise, have the following meanings:--

  "AIDS'', acquired immune deficiency syndrome.

  "AIDS advisory board'', the board established pursuant to section two F.

  "Education'', efforts to inform the public, or groups within the public who are seropositive or at high risk of HIV infection, with targeted information directed specifically at decreasing the incidence of unsafe behavior associated with the transfer of the HIV virus.

  "Experimental treatment'', treatment for the HIV infection or its associated illnesses which has not yet been approved for general use by an appropriate agency of the federal government.

  "Fund'', the Massachusetts AIDS Fund established pursuant to section thirty-five K of chapter ten.

  "HIV'', the human immunodeficiency virus associated with AIDS.

  "Research'', scientific study conducted through community-based efforts to determine the effectiveness of drug and non-drug therapies in combatting the HIV infection and its associated illness, including research into the effectiveness of educational methods and materials.

  "Seropositive'', the status of having tested positive for HIV antibodies.

  "Treatment'', such treatment as is approved by appropriate agencies of the United States government for the HIV infection or its associated illnesses.

Chapter 111: Section 2D. Massachusetts State Health HIV and Hepatitis fund; definitions

[ Text of section as amended by 2016, 406, Sec. 3 effective April 11, 2017. For text effective until April 11, 2017, see above.]

  Section 2D. As used in sections 2D to 2F, inclusive, the following words shall, have the following meanings, unless the context clearly indicates otherwise:--

  "AIDS'', acquired immune deficiency syndrome associated with HIV.

  "AIDS advisory board'', the board established pursuant to section 2F.

  "Education'', efforts to inform the public or groups within the public who are seropositive or at high risk of HIV or viral hepatitis infection with targeted information directed specifically at decreasing the incidence of unsafe behavior associated with the transfer of the HIV virus and viral hepatitis.

  "Experimental treatment'', treatment for viral hepatitis, HIV infection or its associated illnesses which has not yet been approved for general use by an appropriate agency of the federal government.

  ''Fund'', the Massachusetts State Public Health HIV and Hepatitis Fund established pursuant to section 35R of chapter 10.

  ''HIV'', the human immunodeficiency virus associated with AIDS.

  ''Research'', scientific study conducted through community-based efforts to determine the effectiveness of drug and non-drug therapies in combatting viral hepatitis, HIV infection and its associated illness, including research into the effectiveness of educational methods and materials.

  "Seropositive'', the status of having tested positive for HIV or viral hepatitis antibodies.

  "Treatment'', such treatment as is approved by appropriate agencies of the United States government for viral hepatitis, HIV infection or its associated illnesses.